Benefits of radionuclide therapy for neuroendocrine tumors

According to new research, a peptide receptor radiolabeled therapy (PRRT) is effective not only in decreasing tumor size but also in reducing the severity of side effects that often accompany a cancer diagnosis. While many neuroendocrine cancers are incurable, they grow relatively slowly, and life expectancy is relatively long, making quality of life an important factor in treatment.

Read the whole article on Science Daily

More from Science Daily